ID: ALA2089301

Max Phase: Preclinical

Molecular Formula: C39H47ClN4O4S

Molecular Weight: 703.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C(=O)NC12CC3CC(CC(CS(=O)(=O)NC(=O)c4ccc(N5CCN(Cc6ccccc6-c6ccc(Cl)cc6)CC5)cc4)(C3)C1)C2

Standard InChI:  InChI=1S/C39H47ClN4O4S/c1-27(2)36(45)41-39-22-28-19-29(23-39)21-38(20-28,25-39)26-49(47,48)42-37(46)31-9-13-34(14-10-31)44-17-15-43(16-18-44)24-32-5-3-4-6-35(32)30-7-11-33(40)12-8-30/h3-14,27-29H,15-26H2,1-2H3,(H,41,45)(H,42,46)

Standard InChI Key:  HEBQUAUAFFUSRB-UHFFFAOYSA-N

Associated Targets(Human)

Apoptosis regulator Bcl-2/Bcl-2 homologous antagonist/killer 28 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 703.35Molecular Weight (Monoisotopic): 702.3007AlogP: 6.50#Rotatable Bonds: 10
Polar Surface Area: 98.82Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.07CX Basic pKa: 8.35CX LogP: 5.11CX LogD: 5.17
Aromatic Rings: 3Heavy Atoms: 49QED Weighted: 0.25Np Likeness Score: -1.06

References

1. Yusuff N, Doré M, Joud C, Visser M, Springer C, Xie X, Herlihy K, Porter D, Touré BB..  (2012)  Lipophilic Isosteres of a π-π Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction.,  (7): [PMID:24900514] [10.1021/ml300095a]

Source